were pummeled after the company released its
second-quarter 2014 results
last month. The robot maker fell short of revenue estimates, and
missed earnings estimates by a hair if we exclude the benefit of
a one-time tax valuation allowance.
The market usually reacts to the headline numbers in earnings
releases and, while these are important, they never tell the
entire story. Much valuable color is shared during conference
calls, which many investors don't tune into. So, we're going to
cover five key things from iRobot's call that you should
iRobot's flagship product: the Roomba vacuuming bot. Source:
Operating cash flow goal is still on track for
CFO Alison Dean's response to an analyst's question:
Our view for the year hasn't changed, again with the skewing
of our business over the year, as you said, we are in a
[negative cash flow] position in the first half of the year,
but we fully expect to make that up by the second half of the
year and then achieve that high single-digit percent of
It's naturally good news that iRobot's negative operating cash
flow through the first half of 2014 doesn't mean that the company
is off track to hit its cash flow target of a high single-digit
percentage of revenue. iRobot has long been conservative in all
aspects of its guidance. So, it seems likely that Dean would
hedge a bit on her response, and/or the company might even have
notched down its operating cash flow expectation if it weren't
quite positive that it would meet its 2014 target.
Of course, the proof will be in the pudding -- or the cash
flow statement. We'll have to wait until early next year to see
if the company's operating cash flow turns from negative to
positive for the year and hits the target.
As to specifics, iRobot reported operating income of $17.7
million in the first half of 2014, whereas it had a negative
operating cash flow of $7.8 million. In others words, its "books"
showed an operating profit, whereas it lost money from a cash
standpoint. A major culprit - though not the only one - was
Ideally, we'd like the cash flow generated from operations to
be greater than reported operating income. At the least, we'd
like the two numbers to be in the same general ballpark. However,
two quarters is a relatively short period, and cash flow will
vary for numerous good reasons. That said, this divergence
between operating income and cash generated from operations
should be monitored going forward, as it could be cause for
concern if it persists.
Company is confident the defense business is bottoming
PacBot. Source: iRobot.
CEO Colin Angle replied, "[a]bsolutely, absolutely ... and
we're building 2015 backlog," to an analyst who asked, "Is it
fair to say that the confidence surrounding the fact that defense
is bottoming out is stronger today than it was, say, a quarter
If this proves true -- and the solid backlog for the remainder
of 2014 and into 2015 suggests that it likely will -- it will be
good news for investors.The company's defense and security
business has struggled for several years, primarily due to the
U.S. government budget cuts during the past few years, as well as
the government shutdown last year. This segment only accounts for
a small -- and shrinking -- portion of iRobot's revenue. However,
it continues to act as a drag on the company's overall results,
both from revenue growth and profitability standpoints.
Defense business has a solid recurring income
Angle in response to a question:
So, if we categorize this as recurring revenue and in 2014
just to give you a statistic, 60% of our [U.S. Department of
Defense] revenue is related to servicing and upgrading the
existing fleet. And so, while we build out our international
and non-DOD business we've been able to continue to see good
revenue and profit from servicing the installed base.
This solid recurring income stream means there's a floor (no
pun intended, Roomba and Scooba) to how low the revenue in this
segment could fall. More positively, if the defense business
upticks in 2015, as expected, this income stream will increase in
ICU: the growth sweet spot for medical telepresence
Angle in response to a question:
[T]he real area of growth for RP-VITA is in treatment and
involvement in the ICU ... where specialists are needed more
frequently than that rate [referring to 10 times per month,
which is average use for stroke diagnosis applications].
The company's telepresence robots are relatively new, and
account for just a small portion of its overall business -- less
than 5% last year; so, we'll have to see if the growth prospects
pan out as the company hopes. Medical remote presence bots
present a huge opportunity, and the company's early mover status
in this space should continue to help it secure business.
iRobot's medical telepresence bots were first adopted for
stroke diagnosis applications. And Angle noted that RP-VITA is
"really shining," and the company's sales win rate is
"astronomically high" for these applications. That's good news,
of course, but the better news is that the company believes that
nascent intensive care unit applications present an even bigger
opportunity. That's because medical specialists need to monitor
patients very frequently.
Considerable corporate interest in Ava 500 telepresence
Angle said: "[W]e have a very impressive pipeline of
interested parties. We have a number of robots that are in
Ava 500. Source: iRobot.
Ava 500 is a telepresence robot aimed at the enterprise
market. In March, iRobot launched this product in North America
and certain European markets through select certified Cisco
resellers. These are very high-end robots -- costing in the
neighborhood of $70,000 to buy; so, as the company expected, "all
perspective customers to-date want to use the robot on a trial
basis in their respective environments prior to purchasing the
product." As to the trial periods, Angle noted that they're
typically four-to-eight weeks.
This commercial business is only expected to contribute about
3% to revenue in 2014. However, the company expects it to make a
more meaningful contribution in 2015 and beyond.
If you're a believer in investing in megatrends like
robotics, don't miss this
The plastic in your wallet is about to go the way of the
typewriter, the VCR, and the 8-track tape player. When it
does, a handful of investors could stand to get very rich.
new presentation reveals the full story on why
your credit card is about to be worthless
-- and highlights one little-known company sitting at the
epicenter of an earth-shaking movement. Its
stock is up more than 100%
over the last year, but it's still early in the game.
for full details.
5 Things iRobot Corporation's Management Wants
You to Know
originally appeared on Fool.com.
has no position in any stocks mentioned. The Motley Fool
recommends iRobot. Try any of our Foolish newsletter services
free for 30 days
. We Fools may not all hold the same opinions, but we all believe
considering a diverse range of insights
makes us better investors. The Motley Fool has a
Copyright © 1995 - 2014 The Motley Fool, LLC. All rights
reserved. The Motley Fool has a